|
1
|
Rosenberg SW and Lepley JB: Mucormycosis
in leukemia. Oral Surg Oral Med Oral Pathol. 54:26–32.
1982.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Abramson E, Wilson D and Arky RA:
Rhinocerebral phycomycosis in association with diabetic
ketoacidosis. Report of two cases and a review of clinical and
experimental experience with amphotericin B therapy. Ann Intern
Med. 66:735–742. 1967.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Paltauf A: Mycosis mucorina. Arch für
Pathol Anat und Physiol und für Klin Med. 102:543–564. 1885.
|
|
4
|
Manjunatha BS, Das N, Sutariya RV and
Ahmed T: Mucormycosis of the hard palate masquerading as carcinoma.
Clin Pract. 2(e28)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Prabhu RM and Patel R: Mucormycosis and
entomophthoramycosis: A review of the clinical manifestations,
diagnosis and treatment. Clin Microbiol Infect. 10 (Suppl
1):S31–S47. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Janjua OS, Shaikh MS, Fareed MA, Qureshi
SM, Khan MI, Hashem D and Zafar MS: Dental and oral manifestations
of COVID-19 related mucormycosis: Diagnoses, management strategies
and outcomes. J fungi (Basel). 8(44)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Skiada A, Pavleas I and
Drogari-Apiranthitou M: Epidemiology and diagnosis of mucormycosis:
An update. J fungi (Basel). 6(265)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pilmis B, Alanio A, Lortholary O and
Lanternier F: Recent advances in the understanding and management
of mucormycosis. F1000Res. 7(F1000)2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hussain KK, Malavia D, Johnson EM,
Littlechild J, Winlove CP, Vollmer F and Gow NAR: Biosensors and
diagnostics for fungal detection. J fungi (Basel).
6(349)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Singhal N, Kumar M, Kanaujia PK and Virdi
JS: MALDI-TOF mass spectrometry: An emerging technology for
microbial identification and diagnosis. Front Microbiol.
6(791)2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gupta MK, Kumar N, Dhameja N, Sharma A and
Tilak R: Laboratory diagnosis of mucormycosis: Present perspective.
J Family Med Prim Care. 11:1664–1671. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Petrikkos G, Skiada A, Lortholary O,
Roilides E, Walsh TJ and Kontoyiannis DP: Epidemiology and clinical
manifestations of mucormycosis. Clin Infect Dis. 54 (Suppl
1):S23–S34. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bhandari J, Thada PK and Nagalli S:
Rhinocerebral Mucormycosis. In: StatPearls [Internet]. StatPearls
Publishing, Treasure Island, FL, 2022.
|
|
14
|
Corzo-León DE, Chora-Hernández LD,
Rodríguez-Zulueta AP and Walsh TJ: Diabetes mellitus as the major
risk factor for mucormycosis in Mexico: Epidemiology, diagnosis,
and outcomes of reported cases. Med Mycol. 56:29–43.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Goel A, Kini U and Shetty S: Role of
histopathology as an aid to prognosis in rhino-orbito-cerebral
zygomycosis. Indian J Pathol Microbiol. 53:253–257. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Guarner J and Brandt ME: Histopathologic
diagnosis of fungal infections in the 21st century. Clin Microbiol
Rev. 24:247–280. 2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sravani T, Uppin SG, Uppin MS and Sundaram
C: Rhinocerebral mucormycosis: Pathology revisited with emphasis on
perineural spread. Neurol India. 62:383–386. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Groppo ER, El-Sayed IH, Aiken AH and
Glastonbury CM: Computed tomography and magnetic resonance imaging
characteristics of acute invasive fungal sinusitis. Arch
Otolaryngol Head Neck Surg. 137:1005–1010. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Passi N, Wadhwa AC and Naik S:
Radiological spectrum of invasive mucormycosis in COVID-19. BJR
Case Rep. 7(20210111)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Legouge C, Caillot D, Chrétien ML, Lafon
I, Ferrant E, Audia S, Pagès PB, Roques M, Estivalet L, Martin L,
et al: The reversed halo sign: Pathognomonic pattern of pulmonary
mucormycosis in leukemic patients with neutropenia? Clin Infect
Dis. 58:672–678. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Dadwal SS and Kontoyiannis DP: Recent
advances in the molecular diagnosis of mucormycosis. Expert Rev Mol
Diagn. 18:845–854. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Richardson M and Page I: Role of
serological tests in the diagnosis of mold infections. Curr Fungal
Infect Rep. 12:127–136. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Burnham-Marusich AR, Hubbard B, Kvam AJ,
Gates-Hollingsworth M, Green HR, Soukup E, Limper AH and Kozel TR:
Conservation of mannan synthesis in fungi of the zygomycota and
ascomycota reveals a broad diagnostic target. mSphere.
3(e00094)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lackner N, Posch W and Lass-Flörl C:
Microbiological and molecular diagnosis of mucormycosis: From old
to new. Microorganisms. 9(1518)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Skiada A, Lass-Floerl C, Klimko N, Ibrahim
A, Roilides E and Petrikkos G: Challenges in the diagnosis and
treatment of mucormycosis. Med Mycol. 56:93–101. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Potenza L, Vallerini D, Barozzi P, Riva G,
Forghieri F, Zanetti E, Quadrelli C, Candoni A, Maertens J, Rossi
G, et al: Mucorales-specific T cells emerge in the course of
invasive mucormycosis and may be used as a surrogate diagnostic
marker in high-risk patients. Blood. 118:5416–5419. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
White PL: Recent advances and novel
approaches in laboratory-based diagnostic mycology. Med Mycol.
57:S259–S266. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sue MJ, Yeap SK, Omar AR and Tan SW:
Application of PCR-ELISA in molecular diagnosis. Biomed Res Int.
2014(653014)2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Baldin C, Soliman SSM, Jeon HH, Alkhazraji
S, Gebremariam T, Gu Y, Bruno VM, Cornely OA, Leather HL, Sugrue
MW, et al: PCR-based approach targeting mucorales-specific gene
family for diagnosis of mucormycosis. J Clin Microbiol.
56(e00746)2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Pandey M, Xess I, Sachdev J, Yadav U,
Singh G, Pradhan D, Xess AB, Rana B, Dar L, Bakhshi S, et al:
Development of a sensitive and specific novel qPCR assay for
simultaneous detection and differentiation of mucormycosis and
aspergillosis by melting curve analysis. Front Fungal Biol. 2:1–11.
2022.
|
|
31
|
Asdaq SMB, Rajan A, Damodaran A, Kamath
SR, Nair KS, Zachariah SM, Sahu RK, Fattepur S, Sreeharsha N, Nair
A, et al: Identifying mucormycosis severity in indian COVID-19
patients: A nano-based diagnosis and the necessity for critical
therapeutic intervention. Antibiot (Basel). 10(1308)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Dutta P, Lu YJ, Hsieh HY, Lee TY, Lee YT,
Cheng CM and Fan YJ: Detection of candida albicans using a
manufactured electrochemical sensor. Micromachines.
12(166)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Cai D, Xiao M, Xu P, Xu YC and Du W: An
integrated microfluidic device utilizing dielectrophoresis and
multiplex array PCR for point-of-care detection of pathogens. Lab
Chip. 14:3917–3924. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Dixon RV, Skaria E, Lau WM, Manning P,
Birch-Machin MA, Moghimi SM and Ng KW: Microneedle-based devices
for point-of-care infectious disease diagnostics. Acta Pharm Sin B.
11:2344–2361. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Samson R and Dharne M: COVID-19 associated
mucormycosis: Evolving technologies for early and rapid diagnosis.
3 Biotech. 12(6)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Hu L, Zhou P, Zhao W, Hua H and Yan Z:
Fluorescence staining vs. routine KOH smear for rapid diagnosis of
oral candidiasis-A diagnostic test. Oral Dis. 26:941–947.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Potenza L, Vallerini D, Barozzi P, Riva G,
Gilioli A, Forghieri F, Candoni A, Cesaro S, Quadrelli C, Maertens
J, et al: Mucorales-specific T cells in patients with hematologic
malignancies. PLoS One. 11(e0149108)2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Caramalho R, Madl L, Rosam K, Rambach G,
Speth C, Pallua J, Larentis T, Araujo R, Alastruey-Izquierdo A,
Lass-Flörl C and Lackner M: Evaluation of a novel mitochondrial
pan-mucorales marker for the detection, identification,
quantification, and growth stage determination of mucormycetes. J
fungi (Basel). 5(98)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Wang F, Zhang X, Chen G and Zhao Y: Living
bacterial microneedles for fungal infection treatment. Res
(Washington DC). 2020(2760594)2020.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Dannaoui E: Recent developments in the
diagnosis of mucormycosis. J fungi (Basel). 8(457)2022.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Sharma A and Goel A: Mucormycosis: Risk
factors, diagnosis, treatments, and challenges during COVID-19
pandemic. Folia Microbiol (Praha). 67:363–387. 2022.PubMed/NCBI View Article : Google Scholar
|
